Hixon Zuercher’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $535K | Buy |
2,884
+2
| +0.1% | +$371 | 0.17% | 74 |
|
|
2025
Q1 | $604K | Buy |
2,882
+3
| +0.1% | +$628 | 0.21% | 74 |
|
|
2024
Q4 | $512K | Buy |
2,879
+27
| +0.9% | +$4.8K | 0.2% | 72 |
|
|
2024
Q3 | $563K | Buy |
2,852
+2
| +0.1% | +$395 | 0.22% | 69 |
|
|
2024
Q2 | $489K | Hold |
2,850
| – | – | 0.21% | 60 |
|
|
2024
Q1 | $519K | Sell |
2,850
-200
| -7% | -$36.4K | 0.22% | 56 |
|
|
2023
Q4 | $473K | Buy |
3,050
+250
| +9% | +$38.7K | 0.22% | 55 |
|
|
2023
Q3 | $417K | Hold |
2,800
| – | – | 0.22% | 50 |
|
|
2023
Q2 | $377K | Hold |
2,800
| – | – | 0.19% | 54 |
|
|
2023
Q1 | $446K | Buy |
2,800
+200
| +8% | +$31.9K | 0.26% | 47 |
|
|
2022
Q4 | $420K | Hold |
2,600
| – | – | 0.26% | 50 |
|
|
2022
Q3 | $349K | Hold |
2,600
| – | – | 0.22% | 51 |
|
|
2022
Q2 | $398K | Hold |
2,600
| – | – | 0.26% | 48 |
|
|
2022
Q1 | $421K | Hold |
2,600
| – | – | 0.23% | 48 |
|
|
2021
Q4 | $352K | Hold |
2,600
| – | – | 0.18% | 53 |
|
|
2021
Q3 | $280K | Buy |
2,600
+200
| +8% | +$21.5K | 0.16% | 54 |
|
|
2021
Q2 | $270K | Hold |
2,400
| – | – | 0.16% | 55 |
|
|
2021
Q1 | $260K | Hold |
2,400
| – | – | 0.17% | 55 |
|
|
2020
Q4 | $257K | Hold |
2,400
| – | – | 0.18% | 52 |
|
|
2020
Q3 | $210K | Hold |
2,400
| – | – | 0.16% | 52 |
|
|
2020
Q2 | $236K | Buy |
+2,400
| New | +$236K | 0.2% | 49 |
|
|
2020
Q1 | – | Sell |
-2,400
| Closed | -$212K | – | 36 |
|
|
2019
Q4 | $212K | Buy |
+2,400
| New | +$212K | 0.2% | 54 |
|